
Vog-Dalcare 0.3 Tablet
Marketer
Dalmia Healthcare
Salt Composition
Voglibose (0.3mg)
Overview Vog-Dalcare 0.3 Tablet
Dalcare-V 0.3mg tablets are indicated for managing type 2 diabetes. This medication assists in postprandial blood glucose regulation. It's prescribed when dietary modifications and other comparable therapies prove insufficient in controlling hyperglycemia. Dalcare-V 0.3mg should be administered immediately before meals. Dosage frequency is determined by your physician to optimize glycemic control. Discontinuing treatment abruptly is inadvisable without medical consultation; doing so risks elevated blood sugar and potential complications including renal impairment and vision loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Common adverse effects include bloating, abdominal discomfort, anorexia, constipation, and diarrhea. Report any persistent or bothersome side effects to your doctor. While Dalcare-V 0.3mg alone doesn't induce hypoglycemia, concurrent use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Hypoglycemic episodes require treatment with dextrose; sucrose is ineffective. Inform your physician of any kidney or liver conditions before commencing treatment. This medication is contraindicated in patients with bowel inflammation or ulceration (e.g., ulcerative colitis or Crohn's disease). Pregnant or lactating individuals should seek medical advice prior to use. Full disclosure of all medications is crucial for safe usage. Excessive alcohol consumption should be avoided due to increased hypoglycemia risk.
Primary Ingredients of Vog-Dalcare 0.3 Tablet
There is no text provided to rephrase.
Uses of Vog-Dalcare 0.3 Tablet
Managing type 2 diabetes
Major Benefits of Vog-Dalcare 0.3 Tablet:
Consume Vog-Dalcare 0.3 Tablet as directed by your physician, adhering precisely to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Vog-Dalcare 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vog-Dalcare 0.3 Tablet:
Consume Vog-Dalcare 0.3 Tablet exactly as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administration should be on an empty stomach.
How Vog-Dalcare 0.3 Tablet works:
Dalcare Vog 0.3mg tablets are used to manage diabetes. They function by blocking intestinal enzymes that digest complex carbohydrates into simple sugars like glucose, thus moderating postprandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vog-Dalcare 0.3 Tablet and alcohol is unsafe.
PregnancySAFE IF PRESCRIBED
The use of Vog-Dalcare 0.3 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for the fetus; nevertheless, data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
The use of Vog-Dalcare 0.3 Tablet while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vog-Dalcare 0.3 Tablet.
KidneyCAUTION
Patients with severe kidney impairment should use Vog-Dalcare 0.3 Tablet cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Vog-Dalcare 0.3 mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Vog-Dalcare 0.3 Tablet :
Omit any missed Vog-Dalcare 0.3 Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vog-Dalcare 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Category | Alpha-glucosidase inhibitors |
